HK Stock MarketDetailed Quotes

RADIANCE GLO GP (08208)

Watchlist
  • 0.150
  • -0.003-1.96%
Not Open May 18 16:47 CST
108.00MMarket Cap-50.00P/E (TTM)

RADIANCE GLO GP (08208) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
0.82%11.89M
14.78%5.64M
7.01%11.79M
7.89%4.91M
7.82%11.02M
12.20%7.41M
5.18%4.55M
-13.36%1.81M
15.54%10.22M
16.96%6.61M
Operating income
0.82%11.89M
14.78%5.64M
7.01%11.79M
7.89%4.91M
7.82%11.02M
12.20%7.41M
5.18%4.55M
-13.36%1.81M
15.54%10.22M
16.96%6.61M
Cost of sales
-10.68%-8.9M
-6.51%-4.4M
6.21%-8.04M
-0.24%-4.13M
1.99%-8.57M
3.19%-6.21M
4.56%-4.12M
6.95%-2.07M
-8.15%-8.74M
-16.56%-6.42M
Operating expenses
-10.68%-8.9M
-6.51%-4.4M
6.21%-8.04M
-0.24%-4.13M
1.99%-8.57M
3.19%-6.21M
4.56%-4.12M
6.95%-2.07M
-8.15%-8.74M
-16.56%-6.42M
Gross profit
-20.27%2.99M
58.82%1.23M
53.20%3.76M
81.54%777K
65.83%2.45M
534.92%1.2M
6,014.29%428K
-88.57%-264K
93.96%1.48M
32.17%189K
Administrative expenses
2.49%-3.4M
-3.17%-1.76M
-5.19%-3.49M
7.64%-1.71M
-4.11%-3.32M
-20.57%-2.64M
-17.96%-1.85M
-1.82%-838K
12.38%-3.18M
5.40%-2.19M
Impairment and provision
82.13%-47K
----
-305.47%-263K
----
131.84%128K
----
----
----
95.29%-402K
----
-Other impairment is provision
82.13%-47K
----
-305.47%-263K
----
131.84%128K
----
----
----
95.09%-402K
----
Special items of operating profit
-60.67%153K
-4.21%91K
-43.05%389K
-85.58%95K
73.79%683K
160.22%700K
254.30%659K
-26.19%93K
-48.89%393K
-61.46%269K
Operating profit
-176.14%-300K
47.90%-434K
843.40%394K
-9.75%-833K
96.91%-53K
57.34%-738K
44.68%-759K
-20.55%-1.01M
83.86%-1.72M
-17.53%-1.73M
Financing cost
82.98%-8K
82.35%-6K
33.80%-47K
2.86%-34K
-51.06%-71K
-80.00%-54K
-84.21%-35K
-55.56%-14K
-23.68%-47K
-30.43%-30K
Share of profits of associates
----
----
----
----
----
----
----
----
99.06%-1K
183.62%97K
Earning before tax
-188.76%-308K
49.25%-440K
379.84%347K
-9.19%-867K
92.97%-124K
52.38%-792K
41.66%-794K
-25.37%-1.02M
83.64%-1.76M
-3.23%-1.66M
Tax
----
----
----
----
----
----
----
----
--33K
----
After-tax profit from continuing operations
-188.76%-308K
49.25%-440K
379.84%347K
-9.19%-867K
92.83%-124K
52.38%-792K
41.66%-794K
-25.37%-1.02M
83.94%-1.73M
-3.23%-1.66M
Earning after tax
-188.76%-308K
49.25%-440K
379.84%347K
-9.19%-867K
92.83%-124K
52.38%-792K
41.66%-794K
-25.37%-1.02M
83.94%-1.73M
-3.23%-1.66M
Profit attributable to shareholders
-188.76%-308K
49.25%-440K
379.84%347K
-9.19%-867K
92.83%-124K
52.38%-792K
41.66%-794K
-25.37%-1.02M
83.94%-1.73M
-3.23%-1.66M
Basic earnings per share
-180.00%-0.0004
50.00%-0.0006
350.00%0.0005
-9.09%-0.0012
91.67%-0.0002
56.00%-0.0011
47.62%-0.0011
-27.27%-0.0014
85.37%-0.0024
-13.64%-0.0025
Diluted earnings per share
-180.00%-0.0004
50.00%-0.0006
350.00%0.0005
-9.09%-0.0012
91.67%-0.0002
56.00%-0.0011
47.62%-0.0011
-27.27%-0.0014
85.37%-0.0024
-13.64%-0.0025
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
Auditor
--
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
--
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover 0.82%11.89M14.78%5.64M7.01%11.79M7.89%4.91M7.82%11.02M12.20%7.41M5.18%4.55M-13.36%1.81M15.54%10.22M16.96%6.61M
Operating income 0.82%11.89M14.78%5.64M7.01%11.79M7.89%4.91M7.82%11.02M12.20%7.41M5.18%4.55M-13.36%1.81M15.54%10.22M16.96%6.61M
Cost of sales -10.68%-8.9M-6.51%-4.4M6.21%-8.04M-0.24%-4.13M1.99%-8.57M3.19%-6.21M4.56%-4.12M6.95%-2.07M-8.15%-8.74M-16.56%-6.42M
Operating expenses -10.68%-8.9M-6.51%-4.4M6.21%-8.04M-0.24%-4.13M1.99%-8.57M3.19%-6.21M4.56%-4.12M6.95%-2.07M-8.15%-8.74M-16.56%-6.42M
Gross profit -20.27%2.99M58.82%1.23M53.20%3.76M81.54%777K65.83%2.45M534.92%1.2M6,014.29%428K-88.57%-264K93.96%1.48M32.17%189K
Administrative expenses 2.49%-3.4M-3.17%-1.76M-5.19%-3.49M7.64%-1.71M-4.11%-3.32M-20.57%-2.64M-17.96%-1.85M-1.82%-838K12.38%-3.18M5.40%-2.19M
Impairment and provision 82.13%-47K-----305.47%-263K----131.84%128K------------95.29%-402K----
-Other impairment is provision 82.13%-47K-----305.47%-263K----131.84%128K------------95.09%-402K----
Special items of operating profit -60.67%153K-4.21%91K-43.05%389K-85.58%95K73.79%683K160.22%700K254.30%659K-26.19%93K-48.89%393K-61.46%269K
Operating profit -176.14%-300K47.90%-434K843.40%394K-9.75%-833K96.91%-53K57.34%-738K44.68%-759K-20.55%-1.01M83.86%-1.72M-17.53%-1.73M
Financing cost 82.98%-8K82.35%-6K33.80%-47K2.86%-34K-51.06%-71K-80.00%-54K-84.21%-35K-55.56%-14K-23.68%-47K-30.43%-30K
Share of profits of associates --------------------------------99.06%-1K183.62%97K
Earning before tax -188.76%-308K49.25%-440K379.84%347K-9.19%-867K92.97%-124K52.38%-792K41.66%-794K-25.37%-1.02M83.64%-1.76M-3.23%-1.66M
Tax ----------------------------------33K----
After-tax profit from continuing operations -188.76%-308K49.25%-440K379.84%347K-9.19%-867K92.83%-124K52.38%-792K41.66%-794K-25.37%-1.02M83.94%-1.73M-3.23%-1.66M
Earning after tax -188.76%-308K49.25%-440K379.84%347K-9.19%-867K92.83%-124K52.38%-792K41.66%-794K-25.37%-1.02M83.94%-1.73M-3.23%-1.66M
Profit attributable to shareholders -188.76%-308K49.25%-440K379.84%347K-9.19%-867K92.83%-124K52.38%-792K41.66%-794K-25.37%-1.02M83.94%-1.73M-3.23%-1.66M
Basic earnings per share -180.00%-0.000450.00%-0.0006350.00%0.0005-9.09%-0.001291.67%-0.000256.00%-0.001147.62%-0.0011-27.27%-0.001485.37%-0.0024-13.64%-0.0025
Diluted earnings per share -180.00%-0.000450.00%-0.0006350.00%0.0005-9.09%-0.001291.67%-0.000256.00%-0.001147.62%-0.0011-27.27%-0.001485.37%-0.0024-13.64%-0.0025
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----------------Unqualified Opinion--
Auditor ----National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.------National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More